Interferon-Beta, Glatiramer Acetate Equally Effective for Relapsing-Remitting MS

Investigators conducted a meta-analyses to determine whether injectable IFN-β and glatiramer acetate both decrease the annualized relapse rate and slow disease progression in patients with RRMS.

Source link

Related posts

clinical neurology; +286 new citations


Science Blog: CT scans may increase the risk of brain cancer


Novel Narcolepsy Treatment Gets Orphan Drug Designation


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy